日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study

抗PD-1抗体penpulimab联合化疗治疗复发性或转移性鼻咽癌:一项随机、双盲3期研究

Huang, Shuang; Liu, Feng; Qu, Song; Chen, Lisha; Zhou, Ping; Qu, Shenhong; Ai, Xiaohong; Chen, Yong; Liu, Meilian; Wang, Rensheng; Chan, Kelvin Kw; Zhang, Peng; Hu, Chunhong; Wen, Jiyu; Zhang, Jian; Lin, Qin; Li, Xiaojiang; Gu, Kangsheng; Xiang, Li; Wang, Dongxia; Li, Jingao; Lin, Daren; Hu, Desheng; Ding, Jianwu; Wang, Siyang; Huang, Xiaoming; Wang, Lin; Jin, Feng; Pfister, David G; Mak, Milena Perez; Marchi, Pedro Rafael Martins de; Jiang, Yi; Yang, Haihua; Hu, Xiaoye; Liu, Tianrun; Wu, Dehua; Shreenivas, Aditya; Oliveira, Thiago Bueno de; Silva, Carlos Eduardo Baston; Alves, Gustavo Vasconcelos; Li, Xianming; Yao, Zhifang; Lu, Dongmei; Hu, Mingxiu; Wang, Zhongmin Maxwell; Li, Baiyong; Xia, Michelle; Chen, Xiaozhong; Hu, Chaosu; Xu, Tingting

Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trial

高危鼻咽癌患者接受标准放化疗联合同步及辅助卡瑞利珠单抗治疗:一项多中心、随机、开放标签的3期临床试验

You, Rui; Xu, Gui-Qiong; Ding, Xi; Liang, Jin-Hui; Liu, Zhi-Gang; Zou, Xiong; Liu, You-Ping; Hu, Guang-Yuan; Liu, Yi-Min; Duan, Chong-Yang; Liu, Li-Zhi; Zhang, Wei-Jing; Liu, Qian; Li, Hui-Feng; Ouyang, Yan-Feng; Duan, Xiao-Tong; Wang, Qin; Peng, Lan; Liang, Jiong-Lin; Feng, Zheng-Kai; Qin, Zi-Han; Liu, Xiao; He, Zhi-Kun; Zhang, Bin; Long, Guo-Xian; Jiang, Yan-Hui; Lei, Feng; Huang, Pei-Yu; Hua, Yi-Jun; Chen, Ming-Yuan

Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trial

鼻咽癌内侧咽后淋巴结区域保留放疗:一项开放标签、非劣效性、多中心、随机3期试验的五年分析

Wang, Shun-Xin; Tao, Ya-Lan; Gao, Tian-Sheng; Zhang, Ning; Zhou, Guan-Qun; Xie, Fang-Yun; Zhang, Yuan; Guo, Rui; Yang, Yi; Li, Yong-Jie; Liang, Shao-Qiang; Zeng, Yue-Can; Lin, Li; Li, Wen-Fei; Liu, Xu; Xu, Cheng; Chen, Yu-Pei; Lv, Jia-Wei; Liu, Li-Zhi; Li, Hao-Jiang; Li, Ji-Bin; Wen, Hong-Mei; Sun, Ying; Tang, Ling-Long; Liang, Xiao-Yu; Ma, Jun; Mao, Yan-Ping

Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials

开发用于指导个体化免疫治疗策略的鼻咽癌代谢亚型分类器:CONTINUUM 和 DIPPER III 期试验的生物标志物分析

Huang, Sai-Wei; Liang, Ye-Lin; Tao, Ya-Lan; Li, Wen-Fei; Zhou, Guan-Qun; Mao, Yan-Ping; Guo, Rui; Chen, Lei; Xu, Sha; Liu, Xu; Zhang, Ning; Liu, Fang; Shen, Liang-Fang; Zhou, Yang-Ying; Yuan, Ya-Wei; Zou, Guo-Rong; Jin, Feng; Tang, Ling-Long; Sun, Ying; Li, Ying-Qin; Ma, Jun; Liu, Na

Correction: MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma

更正:miR-451通过靶向MIF抑制细胞生长和侵袭,并与鼻咽癌患者的生存率相关。

Liu, Na; Jiang, Ning; Guo, Rui; Jiang, Wei; He, Qing-Mei; Xu, Ya-Fei; Li, Ying-Qin; Tang, Ling-Long; Mao, Yan-Ping; Sun, Ying; Ma, Jun

Fusobacterium nucleatum manipulates host autophagy to promote its intracellular survival and treatment resistance in nasopharyngeal carcinoma.

具核梭杆菌操纵宿主自噬,以促进其在鼻咽癌中的细胞内生存和治疗耐药性。

Wang Jing-Yun, Lu Ying-Qi, Tan Xi-Rong, Ma Sheng-Suo, Dai Jia-Hao, Feng Sen-Yu, Duan Yu-Fei, Bai Jie-Wen, Li Ying-Qing, Gong Sha, Liang Ye-Lin, Huang Sai-Wei, Ma Jun, Xu Cheng, Li Jun-Yan, Liu Na

Endopharyngeal Ultrasound-Guided Transpharyngeal Needle Aspiration for Confirming Retropharyngeal Lymph Nodes' Metastasis among Nasopharyngeal Carcinoma Patients

咽内超声引导下经咽针吸活检术在鼻咽癌患者咽后淋巴结转移诊断中的应用

Xie, Chuanbo; He, Long-Jun; Tan, Wencheng; Xie, Jindong; Li, Yin; Liu, Lizhi; Luo, Guangyu; Bai, Kunhao; Mai, Hai-Qiang; Feng, Guokai; Ma, Jun; Li, Jian-Jun

First-Line Tislelizumab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Cancer: Three-Year Follow-Up of the Phase 3 RATIONALE-309 Randomized Clinical Trial

一线替雷利珠单抗联合化疗治疗复发或转移性鼻咽癌:RATIONALE-309 III期随机临床试验的三年随访

Yang, Yunpeng; Yen, Chia-Jui; Pan, Jianji; Wang, Hui; Qu, Shenhong; Chen, Nianyong; Chen, Xiaozhong; Sun, Yan; He, Xiaohui; Hu, Chaosu; Lin, Lizhu; Wu, Yanjie; Yuan, Shuai; Chen, Chenqi; Xu, Xingxing; Ma, Xiaopeng; Leaw, Shiangjiin; Zhang, Li; Fang, Wenfeng

Five-Year Outcome of Camrelizumab Plus Chemotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Secondary Analysis of the CAPTAIN-1st Randomized Clinical Trial

卡瑞利珠单抗联合化疗治疗复发或转移性鼻咽癌的五年疗效:CAPTAIN-1st随机临床试验的二次分析

Huang, Yan; Sun, Dongchen; Zhou, Huaqiang; Zhou, Ting; Qu, Song; Li, Jingao; Hu, Chaosu; Xu, Mingjun; Li, Weidong; Shen, Liangfang; Wu, Hui; Lang, Jinyi; Hu, Guangyuan; Luo, Zhanxiong; Fu, Zhichao; Qu, Shenhong; Feng, Weineng; Chen, Xiaozhong; Lin, Shaojun; Xie, Bo; Li, Xiaojiang; Sun, Yan; Lin, Zhixiong; Lin, Qin; Lei, Feng; Long, Jianting; Hong, Jinsheng; Huang, Xiaoming; Zeng, Lingzhi; Wang, Peiguo; He, Xiaohui; Zhao, Shen; Chen, Gang; Zhang, Yaxiong; Zhao, Yuanyuan; Fang, Wenfeng; Huang, Chuanpei; Li, Xiaotong; Hong, Shaodong; Zhang, Li; Yang, Yunpeng

Diagnostic Performance of Anti-Epstein-Barr Virus BNLF2b in Suspected Nasopharyngeal Carcinoma

抗 Epstein-Barr 病毒 BNLF2b 在疑似鼻咽癌诊断中的性能

Li, Su-Chen; Li, Fu-Gui; Wu, Shi-Ji; Tang, Min-Zhong; Xiao, Zhen-Zhou; Li, Ting-Dong; Xia, Ning-Shao; Mai, Hai-Qiang; Ji, Ming-Fang; Tang, Lin-Quan; Yuan, Li; Yu, Xia; Li, Hui-Jun; Lin, Ying-Ying; Liu, Wan-Li; Wu, Biao-Hua; Xing, Shan; Chen, Yan-Song; Wu, Ya-Xian; Liu, Li-Ting; Guo, Shan-Shan; He, Xiu-Fang; Li, Xin; Fu, Min-Yi; Long, Guo-Xian; Tang, Hao; Ma, Jin; Gao, Tian-Sheng; Ye, Jin-Bin; Li, Lu-Jun; Guo, Qiao-Juan; Lv, Xiao-Fei; Xiao, Xue-Hong; Lu, Shao-Lu; Zhong, Jing; Li, Zhi-Ming; Song, Ming; Chen, Shu-Wei; Lv, Xing; Xia, Wei-Xiong; Hua, Yi-Jun; Wang, Lin; Yang, Qi; Zou, Xiong; Liang, Hu; Miao, Jing-Jing; Xie, Rui-Ling; Liu, Sai-Lan; Li, Xiao-Yun; Sun, Xue-Song; Ge, Sheng-Xiang; Zhang, Jun